Cents front office gear up for 50th season merrittherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from merrittherald.com Daily Mail and Mail on Sunday newspapers.
Enhertu reduced the risk of disease progression or death compared to chemotherapy in certain patients with metastatic breast cancer - News - PharmaTimes
Researchers found that at 36 months, the estimated event-free survival was 84.5 and 76.8% in the pembrolizumab-chemotherapy and placebo-chemotherapy groups, respectively.